Friday, March 14, 2025
spot_img

Oportun to Present at Sidoti March Virtual Investor Conference

SAN CARLOS, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company, today announced that it will participate in the upcoming Sidoti March Virtual Investor Conference.

Oportun’s Chief Executive Officer, Raul Vazquez, and Chief Financial Officer & Chief Administrative Officer, Jonathan Coblentz, will present and participate in investor meetings at the conference. The presentation will begin at 4:00 pm ET on March 20th and can be accessed live at this link.

A link to the presentation webcast will also be accessible in the “IR calendar” section of Oportun’s Investor Relations website under “News & Events” at https://investor.oportun.com. A replay will be available for an additional 90 days via the same link following the conference.

About Oportun 
Oportun (Nasdaq: OPRT) is a mission-driven financial services company that puts its members’ financial goals within reach. With intelligent borrowing, savings, and budgeting capabilities, Oportun empowers members with the confidence to build a better financial future. Since inception, Oportun has provided more than $19.7 billion in responsible and affordable credit, saved its members more than $2.4 billion in interest and fees, and helped its members save an average of more than $1,800 annually. For more information, visit Oportun.com.

Investor Contact
Dorian Hare
(650) 590-4323
[email protected]

Media Contact
Michael Azzano
Cosmo PR for Oportun
[email protected]
(415) 596-1978

This press release was published by a CLEAR® Verified individual.

Powered by SlickText.com

Hot this week

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Topics

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Parsons to Present at the Bank of America Global Industrials Conference

CHANTILLY, Va., March 13, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img